Luqi Chi, MD, MSCE, FACP

Luqi Chi, MD, MSCE, FACP, is a professor of neurology and sleep medicine. She received her medical degree and a master’s degree in cardiopulmonary pathophysiology in China. She subsequently completed her residency training in internal medicine and fellowship training in pulmonary and critical care medicine. After coming to the U.S. in 1998, she went on to complete her U.S. residency at Rochester General Hospital in Rochester, New York, and fellowship training in sleep medicine at the University of Pennsylvania School of Medicine in Philadelphia. She also received a master’s degree in Clinical Epidemiology (MSCE) at the University of Pennsylvania School of Medicine. Prior to joining Washington University, Chi practiced sleep medicine in Philadelphia, holding a faculty position at both the University of Pennsylvania School of Medicine and Jefferson Medical College.

Chi’s practice philosophy is patient-centered, forming a working partnership with the patient and the patient’s family in which the patient takes an active role in his/her treatment. Chi offers a multidisciplinary approach and greatly values the patient as an individual. She uses her knowledge, compassion, analytical thinking, and problem-solving skills to offer passionate care that leads to the best possible outcome for each patient.

Chi’s areas of clinical interest include outpatient and hospital sleep medicine associated with obstructive sleep apnea, central sleep apnea, obesity hypoventilation syndrome, circadian rhythm disorders, insomnia, hypersomnia, narcolepsy, restless leg syndrome, periodic limb movement disorder, and parasomnias (sleep walking, sleep-related eating disorder, REM behavior disorder, etc). 

Chi has expertise in respiratory failure caused by neuromuscular diseases (such as ALS), chest wall deformity and lung disease (such as COPD) using noninvasive ventilation (NIV) delivered through a variety of ventilator modes.

Chi is a site principal investigator of ongoing NIH funded randomized control clinical trials: (1) Impact of treating obstructive sleep apnea on mild cognitive impairment; and (2) the effect of treating central sleep apnea with nocturnal home oxygen therapy on hospital readmission and mortality.